← FDA DRUG APPROVALS
FDA ANDA · ANDA209524
PANTOPRAZOLE SODIUM I.V.
pantoprazole sodium
Sponsor: HANGZHOU ZHONGMEI
APPLICATION
ANDA209524
TYPE
ANDA
ORIGINAL APPROVAL
2021-08-30
LATEST ACTION
2025-05-07
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
PANTOPRAZOLE SODIUMPrescription
PANTOPRAZOLE SODIUM EQ 40MG BASE/VIAL · INJECTABLE · INTRAVENOUS
Approval history
2025-05-07Labeling · Supplement 4 · standardAP
2023-04-12Labeling · Supplement 1 · standardAP
2021-08-30UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.